Net sales for the American market increased by 2 percent during the second quarter while the Europe net sales decreased by 8 percent and the international sales increased by 12 percent. The company foresees an improving economy, favorable demographics and product innovation to lead to a successful future.
Knee sales increased by 2 percent worldwide, extremity sales by 21 percent and sports medicine sales by 16 percent worldwide. The sales of spine products experienced a 3 percent decrease during the second quarter.
Read the release on Biomet’s 2Q FY 2011 financial report.
Read other coverage on Biomet:
– Biomet Completes Enrollment for FDA Trial for PRP Device for Tennis Elbow Treatment
– Biomet Nederland, Small Bone Innovations Sign Distribution Agreement
– Biomet Acquires Massachusetts’ Cytosol Laboratories
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
